N
TELA icon

Nuveen’s TELA Bio TELA Stock Holding History

Nuveen’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-102,782
Closed -$583K – 3414
2024
Q1 		$583K Buy
102,782
+71,919
+233% +$474K ﹤0.01% 2925
2023
Q4 		$204K Buy
30,863
+8,220
+36% +$47.5K ﹤0.01% 3213
2023
Q3 		$181K Hold
22,643
– – ﹤0.01% 3053
2023
Q2 		$229K Buy
+22,643
New +$232K ﹤0.01% 3063
2021
Q2 		– Sell
-18,098
Closed -$270K – 3528
2021
Q1 		$270K Hold
18,098
– – ﹤0.01% 3194
2020
Q4 		$272K Hold
18,098
– – ﹤0.01% 3155
2020
Q3 		$299K Hold
18,098
– – ﹤0.01% 3088
2020
Q2 		$235K Buy
+18,098
New +$238K ﹤0.01% 3073

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Nuveen's TELA Position: Q2 2024 in Review

Nuveen sold out of TELA Bio (TELA) in Q2 2024, closing a stake of 102,782 shares — an estimated $583K sold.

Nuveen first reported a position in TELA in Q2 2020 and held it in 8 quarters. The position peaked at $583K in Q1 2024. 68 funds tracked by Wall St. Rank hold TELA as of Q2 2024.

  • Nuveen reported no remaining TELA Bio position as of Q2 2024 after selling out during the quarter.
  • Nuveen sold 102,782 TELA Bio shares in Q2 2024, an estimated $583K.
  • Nuveen first reported a position in TELA Bio in Q2 2020 and held it in 8 quarters.
  • Nuveen's TELA Bio position peaked at $583K in Q1 2024.
  • 68 funds tracked by Wall St. Rank held TELA Bio as of Q2 2024.

Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.